SHPMF (Shanghai Pharmaceuticals Holding Co) Tariff Resilience Score: 4/10 (As of Jul. 01, 2026)


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
77 GF Score
Price $1.46
GF Value $1.89
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Tariff Resilience Score?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 77 Tariff Resilience Score is 4 as of Jul. 01, 2026. GuruFocus rates SHPMF with a GF Score™ of 77/100 and a GF Value™ of $1.89. The stock has 4 warning signs investors should review. Among 119 Medical Distribution companies, Shanghai Pharmaceuticals Holding Co ranks better than 87.39% on this metric.

Shanghai Pharmaceuticals Holding Co has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Shanghai Pharmaceuticals Holding Co has Shanghai Pharmaceuticals is highly exposed to tariffs due to its extensive global supply chain and export activities. Previous tariff changes have impacted revenue, and while the company is exploring alternative suppliers, its current dependency on international trade remains a vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Shanghai Pharmaceuticals Holding Co might have Average Resilient.

Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Shanghai Pharmaceuticals Holding Co Tariff Resilience Score Related Terms

SHPMF vs MCK, CAH, COR: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Pharmaceuticals Holding Co Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Tariff Resilience Score falls into.


SHPMF
77GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Tariff Resilience Score of 4 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #15 out of 119 companies in the Medical Distribution industry, placing it in the top 12.6%.
Is Shanghai Pharmaceuticals Holding Co's Tariff Resilience Score too high?
Shanghai Pharmaceuticals Holding Co's current Tariff Resilience Score is 4. Based on the distribution chart, Shanghai Pharmaceuticals Holding Co ranks #15 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Tariff Resilience Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #15 out of 119 companies for Tariff Resilience Score. This places Shanghai Pharmaceuticals Holding Co in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Shanghai Pharmaceuticals Holding Co's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Tariff Resilience Score of 4. The stock's GF Value™ is $1.89, compared to a current price of $1.46 — trading 22.8% below its estimated fair value. The current Tariff Resilience Score is 4. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Tariff Resilience Score is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 22.8% below its estimated GF Value™ of $1.89.

Key valuation signals for SHPMF:

  • Tariff Resilience Score: 4
  • GF Value™: $1.89 vs. price of $1.46 (22.8% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score

Get the complete analysis for SHPMF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.89
GF Value